GRANULES INDIA LIMITED
Regd Office : 2nd Floor, 3rd Block, My Home Hub
Madhapur, Hyderabad 500 081
UNAUDITED FINANCIAL RESULTS 
FOR THE QUARTER  ENDED 30th SEPTEMBER, 2008
Rs. Lakhs
S No Particulars 3 months ended              30th Sept, 2008 Corresponding 3 months ended in the previous year             30th Sept, 2007  Previous accounting year ended                      30th June, 2008 
   Unaudited  Unaudited Audited 
1 Net sales / Income from Operations                8,144.60                5,003.06              21,414.65
2 Expenditure      
  a) (Increase)/decrease in stocks & work in progress                  (517.09)                   (54.11)                 (869.25)
  b) Consumption of Raw Materials                5,756.33                2,932.56              13,347.33
  c) Manufacturing Expenses                   510.21                  398.86                1,756.77
  d) Employee cost                   403.25                  353.15                1,389.97
  e) Administrative Expenses                   259.33                  188.75                  837.04
  f) Foreign Exchange Fluctuations                   245.72                    42.83                    22.63
  g) Selling & Distribution Expenses                   491.29                  369.43                1,501.67
  h) Depreciation                   259.84                  232.47                  972.09
  i) Other expenditure                      9.40                      3.41                    46.56
        Total                7,418.28                4,467.36              19,004.82
3 Other Income                   (19.09)                     (8.17)                   (68.51)
4 Interest and Bank charges                   391.07                  268.49                1,197.22
5 Profit before taxation                   354.34                  275.38                1,281.12
6 Tax expense      
           Current Tax Expense                     40.15                    26.14                  145.15
           Deferred Tax Expense                    36.79                    44.68                  210.85
           Fringe Benefit Tax                      3.23                      2.66                    11.70
7 Net Profit 274.17 201.90 913.42
8 Paid-up share capital (Face Value of Rs.10/- each)                2,005.72                2,004.11                2,005.72
9 Reserves excluding Revaluation Reserve                         -                           -                15,894.21
10 Earning Per Share (EPS)      
  Basic Earnings per share (Rs.)*                      1.37                      1.01                      4.55
11 Public Shareholding      
    - No. of shares            12,644,517            13,688,103            13,547,423
    - Percentage of shareholding 63.04% 68.30% 67.54%
* Not Annualised for quarter ending
NOTES :
1) The above  results were reviewed by the Audit Committee and approved by the Board at its meeting held  on 
    20th October, 2008 and were subjected to limited review by Statutory Auditors.
2) Tablet division had commenced commercial operations from 23rd September, 2008.
3) Foreign Exchange Fluctuations of Rs.245.72 lakhs (net) includes re-statement of foreign currency loans, 
     receivables and payables.
4) 16,00,000 share warrants issued have lapsed on 27th September, 2008 and hence forfeited.
5) The above unaudited results are for the single entity and do not include consolidated financials
6) The company has not received any complaints from investors during the quarter 1st July '08 to 30th Sept '08
    and no complaints were pending from previous quarter.
7) The Company operates only in the segment of Pharmaceuticals.
8) Figures are regrouped wherever necessary.
 for and on behalf of the board 
Place  : Hyderabad        Dr.C.Nageswara Rao 
Date   :  20.10.2008                Chairman